Daniel E. Kolker

Array ( [id] => 9003090 [patent_doc_number] => 20130224215 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-29 [patent_title] => 'A B Cell Depleting Agent for the Treatment of Atherosclerosis' [patent_app_type] => utility [patent_app_number] => 13/790771 [patent_app_country] => US [patent_app_date] => 2013-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 9961 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13790771 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9771156 [patent_doc_number] => 20140294819 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-02 [patent_title] => 'CANINE/FELINE CD20 BINDING EPITOPE AND COMPOSITIONS FOR BINDING THERETO' [patent_app_type] => utility [patent_app_number] => 14/351392 [patent_app_country] => US [patent_app_date] => 2012-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 19870 [patent_no_of_claims] => 162 [patent_no_of_ind_claims] => 41 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14351392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8429660 [patent_doc_number] => 20120251535 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-04 [patent_title] => 'COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODY' [patent_app_type] => utility [patent_app_number] => 13/524837 [patent_app_country] => US [patent_app_date] => 2012-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12308 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13524837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8289783 [patent_doc_number] => 20120178107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha' [patent_app_type] => utility [patent_app_number] => 13/340805 [patent_app_country] => US [patent_app_date] => 2011-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20858 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13340805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8792138 [patent_doc_number] => 20130109107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-02 [patent_title] => 'DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASE' [patent_app_type] => utility [patent_app_number] => 13/698226 [patent_app_country] => US [patent_app_date] => 2011-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 20237 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13698226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8187161 [patent_doc_number] => 20120116054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'CONCENTRATED PROTEIN LYOPHILATES, METHODS, AND USES' [patent_app_type] => utility [patent_app_number] => 13/102733 [patent_app_country] => US [patent_app_date] => 2011-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 40476 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20120116054.pdf [firstpage_image] =>[orig_patent_app_number] => 13102733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6174251 [patent_doc_number] => 20110177066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASES' [patent_app_type] => utility [patent_app_number] => 13/033336 [patent_app_country] => US [patent_app_date] => 2011-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 41621 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20110177066.pdf [firstpage_image] =>[orig_patent_app_number] => 13033336 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8146690 [patent_doc_number] => 08163700 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-24 [patent_title] => 'Inhibitors of myelin-associated glycoprotein (MAG) activity for regulating neural growth and regeneration' [patent_app_type] => utility [patent_app_number] => 12/945683 [patent_app_country] => US [patent_app_date] => 2010-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 35799 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 309 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/163/08163700.pdf [firstpage_image] =>[orig_patent_app_number] => 12945683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6026908 [patent_doc_number] => 20110054158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'POLYNUCLEOTIDES ENCODING CLASS II CYTOKINE RECEPTOR-7' [patent_app_type] => utility [patent_app_number] => 12/899819 [patent_app_country] => US [patent_app_date] => 2010-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13166 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20110054158.pdf [firstpage_image] =>[orig_patent_app_number] => 12899819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5943433 [patent_doc_number] => 20110104053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'HUMAN IgM ANTIBODIES, AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF PARTICULARLY IN THE CENTRAL NERVOUS SYSTEM' [patent_app_type] => utility [patent_app_number] => 12/845936 [patent_app_country] => US [patent_app_date] => 2010-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 88 [patent_figures_cnt] => 88 [patent_no_of_words] => 64108 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104053.pdf [firstpage_image] =>[orig_patent_app_number] => 12845936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6095377 [patent_doc_number] => 20110002945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'Use of immunoglobulin heavy and light chains or fragments thereof to bind to aggregated amyloidogenic proteins' [patent_app_type] => utility [patent_app_number] => 12/803384 [patent_app_country] => US [patent_app_date] => 2010-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7003 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20110002945.pdf [firstpage_image] =>[orig_patent_app_number] => 12803384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6098422 [patent_doc_number] => 20110003972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'STABILIZING POLYPEPTIDES WHICH HAVE BEEN EXPOSED TO UREA' [patent_app_type] => utility [patent_app_number] => 12/819979 [patent_app_country] => US [patent_app_date] => 2010-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9814 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20110003972.pdf [firstpage_image] =>[orig_patent_app_number] => 12819979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6581482 [patent_doc_number] => 20100291094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'NUCLEIC ACID ENCODING 238P1B2 USEFUL IN DETECTING CANCER' [patent_app_type] => utility [patent_app_number] => 12/785360 [patent_app_country] => US [patent_app_date] => 2010-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 194549 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291094.pdf [firstpage_image] =>[orig_patent_app_number] => 12785360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7510759 [patent_doc_number] => 20110256553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'Methods' [patent_app_type] => utility [patent_app_number] => 12/763005 [patent_app_country] => US [patent_app_date] => 2010-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15448 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20110256553.pdf [firstpage_image] =>[orig_patent_app_number] => 12763005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6550449 [patent_doc_number] => 20100233180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'ANTIBODIES THAT BIND TO AN EPITOPE ON THE HUNTINGTON\'S DISEASE PROTEIN' [patent_app_type] => utility [patent_app_number] => 12/727918 [patent_app_country] => US [patent_app_date] => 2010-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 16536 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20100233180.pdf [firstpage_image] =>[orig_patent_app_number] => 12727918 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6539878 [patent_doc_number] => 20100221840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'METHODS FOR TESTING FOR AND INHIBITING THE DEVELOPMENT OF HUNTINGTON\'S DISEASE' [patent_app_type] => utility [patent_app_number] => 12/719361 [patent_app_country] => US [patent_app_date] => 2010-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3201 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20100221840.pdf [firstpage_image] =>[orig_patent_app_number] => 12719361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6499118 [patent_doc_number] => 20100215576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'DIAGNOSIS AND TREATMENT OF NEUROECTODERMAL TUMORS' [patent_app_type] => utility [patent_app_number] => 12/706383 [patent_app_country] => US [patent_app_date] => 2010-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 7926 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20100215576.pdf [firstpage_image] =>[orig_patent_app_number] => 12706383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6527811 [patent_doc_number] => 20100203631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'ANTIBODIES TO ALPHA-SYNUCLEIN' [patent_app_type] => utility [patent_app_number] => 12/695085 [patent_app_country] => US [patent_app_date] => 2010-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12605 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20100203631.pdf [firstpage_image] =>[orig_patent_app_number] => 12695085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7795389 [patent_doc_number] => 08124095 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-28 [patent_title] => 'Fusion proteins for delivery of erythropoietin to the CNS' [patent_app_type] => utility [patent_app_number] => 12/688842 [patent_app_country] => US [patent_app_date] => 2010-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 41596 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/124/08124095.pdf [firstpage_image] =>[orig_patent_app_number] => 12688842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4599722 [patent_doc_number] => 07977317 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-12 [patent_title] => 'Compositions and methods for modulating blood-brain barrier transport' [patent_app_type] => utility [patent_app_number] => 12/683651 [patent_app_country] => US [patent_app_date] => 2010-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 47 [patent_no_of_words] => 32660 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/977/07977317.pdf [firstpage_image] =>[orig_patent_app_number] => 12683651 [rel_patent_id] =>[rel_patent_doc_number] =>)